COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review and meta-analysis
JW Senefeld, M Franchini, C Mengoli… - JAMA Network …, 2023 - jamanetwork.com
Importance Patients who are immunocompromised have increased risk for morbidity and
mortality associated with coronavirus disease 2019 (COVID-19) because they less …
mortality associated with coronavirus disease 2019 (COVID-19) because they less …
A multi-center, open-label, randomized controlled trial to evaluate the efficacy of convalescent plasma therapy for coronavirus disease 2019: A trial protocol (COVIPLA …
N Tomita, S Saito, J Terada-Hirashima, A Mikami… - Life, 2022 - mdpi.com
Background: Coronavirus disease 2019 is a global public health concern. As of December
2020, the therapeutic agents approved for coronavirus disease 2019 in Japan were limited …
2020, the therapeutic agents approved for coronavirus disease 2019 in Japan were limited …
Effectiveness of convalescent plasma therapy for COVID 19 patients infected with variants of concerns
EM Kurniawati, IS Putri, DM Widiatmaja… - Anaesthesia, Pain & …, 2022 - repository.unair.ac.id
ABSTRACT COVID-19 cases in Indonesia seemed to be increasing by each passing day at
the time of writing this review, more positive cases discovered than the recovered ones. With …
the time of writing this review, more positive cases discovered than the recovered ones. With …
[PDF][PDF] COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review. 2
Interventions–Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration 111
http://www. cochranehandbook. org.]. The Cochrane'Risk of bias' tool for RCTs addresses …
http://www. cochranehandbook. org.]. The Cochrane'Risk of bias' tool for RCTs addresses …
[PDF][PDF] Visuddho 2, Prameswari FU, Zahrani M, Putra FN, Nugraha D, Widiastara AA. Effectiveness of convalescent plasma therapy for COVID-19 patients infected with …
EM Kurniawati, IS Putri, DM Widiatmaja, VM Praba - researchgate.net
COVID-19 cases in Indonesia seemed to be increasing by each passing day at the time of
writing this review, more positive cases discovered than the recovered ones. With the …
writing this review, more positive cases discovered than the recovered ones. With the …
Fallbericht: Therapie mit Rekonvaleszentenplasma bei B-Zell-defizientem Patienten nach CAR‑T-Zell-Therapie
B Bošnjak - thieme-connect.com
Bei B-Zell-defizienten Patienten hat sich die Behandlung mit Rekonvaleszentenplasma (CP)
als erfolgreich bei der Bekämpfung der SARS‑CoV‑2-Infektion erwiesen. Der Einsatz der CP …
als erfolgreich bei der Bekämpfung der SARS‑CoV‑2-Infektion erwiesen. Der Einsatz der CP …
Hypogammaglobulinaemia and pancytopenia: case report
B Bosnjak - Reactions, 1881 - ncbi.nlm.nih.gov
The female, who had refractory diffuse large B-cell lymphoma, received tisagenlecleucel on
23 March 2020. Subsequently, she developed hypogammaglobulinaemia and prolonged …
23 March 2020. Subsequently, she developed hypogammaglobulinaemia and prolonged …